Related Experiment Video
Updated: Feb 15, 2026

Employing Aeroponic Systems for the Clonal Propagation of Cannabis
Published on: December 1, 2021
Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation
Phillip M Radke1, Ali Mokhtarzadeh1, Michael S Lee1,2,3
1Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USA.
Abstract:
The objective of this study was to observe the effect of medical cannabis in benign essential blepharospasm (BEB) as an adjunct to botulinum toxin. A retrospective chart review was performed on patients certified for medical cannabis use for BEB from September 2015 to May 2016. Patient demographics and responses, cannabis history, and severity indices were collected. Ten patients were certified for medical cannabis use. Five met the inclusion criteria, which was any patient with a diagnosis of BEB receiving standard botulinum toxin treatment who had started medical cannabis treatment by a registered distributor within the state, and was contactable by phone. Four patients discontinued use. Three out of four patients (75%) reported symptomatic improvement. Medical cannabis is an accepted therapy for muscle spastic disorders. Its potential as an adjunctive therapy for BEB remains unknown, and further investigations would be of benefit.
Related Concept Videos
Naturalistic Observations
Inhaled Medications
Observational Learning
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Actor-Observer Effect
Endocarditis III: Medical Management

